NCT02238496 2023-05-25Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasColumbia UniversityPhase 1 Completed10 enrolled
NCT00590954 2020-10-19Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant GliomasMemorial Sloan Kettering Cancer CenterPhase 2 Completed32 enrolled 8 charts